EirGen Pharma product EIR-115 approved by PMDA

EirGen Pharma are pleased to announce our Letrozole Japan application has been approved by the PMDA (the Japanese Health Authority) after the application being filed in February 2014.
Letrozole was developed for first line treatment in postmenopausal women with hormone-dependent breast cancer.